Global Insulin Raw Material Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Insulin Raw Material Market Insights, Forecast to 2034
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China. In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Global Insulin Raw Material market is expected to reach to US$ 2008 million in 2024, with a positive growth of %, compared with US$ 1943 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Insulin Raw Material industry is evaluated to reach US$ 2482.7 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The Insulin Raw Material market is driven by the increasing prevalence of diabetes and the growing demand for insulin production to address the global healthcare burden. Insulin, a vital hormone for managing blood sugar levels, requires high-quality raw materials for its synthesis. The rise in diabetes cases, both type 1 and type 2, contributes to market growth as pharmaceutical companies seek reliable sources of raw materials to meet the escalating insulin demand. Moreover, advancements in biotechnology and genetic engineering align with improved insulin production methods and potential innovations in insulin analogs. However, the market also faces challenges, including the complexity of insulin production processes and the need to adhere to stringent regulatory standards for quality and safety. Additionally, addressing affordability concerns and potential supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on sustainable sourcing, research and development for efficient production methods, and addressing the challenges to meet the increasing demand for insulin while ensuring its accessibility to a diverse diabetic population worldwide.
Report Covers
This report presents an overview of global Insulin Raw Material market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Insulin Raw Material market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Segment by Type
Regular Human Insulin
Insulin Analogue
Fast-acting
Intermediate-acting
Long-acting
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Insulin Raw Material plant distribution, commercial date of Insulin Raw Material, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Insulin Raw Material introduction, etc. Insulin Raw Material Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Insulin Raw Material
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Insulin Raw Material market is expected to reach to US$ 2008 million in 2024, with a positive growth of %, compared with US$ 1943 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Insulin Raw Material industry is evaluated to reach US$ 2482.7 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The Insulin Raw Material market is driven by the increasing prevalence of diabetes and the growing demand for insulin production to address the global healthcare burden. Insulin, a vital hormone for managing blood sugar levels, requires high-quality raw materials for its synthesis. The rise in diabetes cases, both type 1 and type 2, contributes to market growth as pharmaceutical companies seek reliable sources of raw materials to meet the escalating insulin demand. Moreover, advancements in biotechnology and genetic engineering align with improved insulin production methods and potential innovations in insulin analogs. However, the market also faces challenges, including the complexity of insulin production processes and the need to adhere to stringent regulatory standards for quality and safety. Additionally, addressing affordability concerns and potential supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on sustainable sourcing, research and development for efficient production methods, and addressing the challenges to meet the increasing demand for insulin while ensuring its accessibility to a diverse diabetic population worldwide.
Report Covers
This report presents an overview of global Insulin Raw Material market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Insulin Raw Material market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Segment by Type
Regular Human Insulin
Insulin Analogue
Segment by Application
Fast-acting
Intermediate-acting
Long-acting
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Insulin Raw Material plant distribution, commercial date of Insulin Raw Material, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Insulin Raw Material introduction, etc. Insulin Raw Material Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Insulin Raw Material
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports